• {%brandMenuItems%}
    • {%itemName%} {%arrowSpan%}
    • {%itemName%} {%arrowSpan%}
    • {%selfProduct%}
      • {%languages%}
    • This website is for UK Healthcare Professionals only


      November: Episode 6     Watch time: 20 min

      EADV 2020: congress highlights

      The sixth episode looks at the latest updates and hot topics relating to SKYRIZI® (risankizumab) and the psoriasis treatment landscape from the EADV 2020 virtual congress.

      Podcast Series Host

      Dr Laura Savage

      Consultant Dermatologist at Leeds Centre for Dermatology, Chapel Allerton Hospital (Leeds Teaching Hospitals NHS Trust) and an Honorary Senior Lecturer at University of Leeds

      Podcast Guest Speakers

      Dr Richard Woolf

      Consultant Dermatologist, St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust


      Dr Margo Gkini

      Consultant Dermatologist



      JULY: Episode 1

      Clinical trial spotlight - risankizumab and secukinumab head-to-head in plaque psoriasis

      AUGUST: Episode 2

      Psoriasis in the time of COVID-19: an era of virtual clinics?             

      SEPTEMBER: Episode 3

      Psoriasis in practice: BAD guideline updates                               

      OCTOBER: Episode 4

      BAD 2020: virtual congress highlights

      NOVEMBER: Episode 5

      Are all IL-23s the same?                    

      DECEMBER: Episode 6

      EADV 2020: congress highlights       


      1. SKYRIZI (risankizumab) Summary of Product Characteristics.

      UK-RISN-210518 Date of Preparation: October 2021